These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21309053)

  • 21. Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.
    Grønbaek H; Nielsen B; Frystyk J; Orskov H; Flyvbjerg A
    J Endocrinol; 1995 Oct; 147(1):95-102. PubMed ID: 7490542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of growth hormone and insulin-like growth factor-I in experimental renal growth and scarring.
    el Nahas AM
    Am J Kidney Dis; 1991 Jun; 17(6):677-9. PubMed ID: 2042648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor in renal hypertrophy in streptozotocin-diabetic rats.
    Guh JY; Lai YH; Shin SJ; Chuang LY; Tsai JH
    Nephron; 1991; 59(4):641-7. PubMed ID: 1766505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes.
    Flyvbjerg A; Orskov H
    Acta Endocrinol (Copenh); 1990 Mar; 122(3):374-8. PubMed ID: 2327216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal hypertrophy, growth factors, and nephropathy in diabetes mellitus.
    Schwieger J; Fine LG
    Semin Nephrol; 1990 May; 10(3):242-53. PubMed ID: 2190281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathogenesis of the diabetic kidney and the role of insulin-like growth factor.
    Cohen SE; Popovtzer MM
    Int J Artif Organs; 1997 May; 20(5):244-50. PubMed ID: 9209923
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal protein synthesis in diabetes mellitus: effects of insulin and insulin-like growth factor I.
    Barac-Nieto M; Liu SM; Spitzer A
    Am J Kidney Dis; 1991 Jun; 17(6):658-60. PubMed ID: 2042644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal hypertrophy in experimental diabetes.
    Flyvbjerg A; Mogensen CE; Osterby R; Orskov H
    J Diabet Complications; 1991; 5(2-3):62-4. PubMed ID: 1770054
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy.
    Jepsen MR; Østergaard JA; Conover CA; Wogensen L; Birn H; Krag SP; Fenton RA; Oxvig C
    Metabolism; 2022 Jul; 132():155218. PubMed ID: 35588861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The insulin-like growth factor system in kidney diseases.
    Richmond EJ; Uzri A; Rogol AD
    Nephron; 2001 Sep; 89(1):5-9. PubMed ID: 11528224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of growth performance in disease: reactive nitrogen compounds and their impact on cell proteins.
    Elsasser TH; Kahl S; Rumsey TS; Blum JW
    Domest Anim Endocrinol; 2000 Aug; 19(2):75-84. PubMed ID: 11025187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF-1 and macrovascular complications of diabetes: alternative interpretations of recently published data.
    Conti E; Pitocco D; Capoluongo E; Zuppi C; Ghirlanda G; Crea F; Andreotti F
    Diabetes Care; 2003 May; 26(5):1653-4; author reply 1654-5. PubMed ID: 12716855
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of adrenal cortical hypertrophy in diabetic rats by the use of insulin.
    FIELD JB
    Endocrinology; 1955 May; 56(5):499-506. PubMed ID: 14365702
    [No Abstract]   [Full Text] [Related]  

  • 34. Huaju Xiaoji Formula Regulates ERS-lncMGC/miRNA to Enhance the Renal Function of Hypertensive Diabetic Mice with Nephropathy.
    Zhang Z; Fu X; Zhou F; Zhang D; Xu Y; Fan Z; Wen S; Shao Y; Yao Z; He Y
    J Diabetes Res; 2024; 2024():6942156. PubMed ID: 38282657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy.
    Fan C; Gao Y; Sun Y
    Front Endocrinol (Lausanne); 2023; 14():1191768. PubMed ID: 37492198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation analysis of serum IGF-1 and IL-6 and urinary albumin/creatinine ratio in patients with type 2 diabetic kidney disease.
    Liu GW; Zeng JE; Li LF
    Front Endocrinol (Lausanne); 2022; 13():1082492. PubMed ID: 36568065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth Hormone and IGF1 Actions in Kidney Development and Function.
    Gurevich E; Segev Y; Landau D
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ramipril can alleviate the accumulation of renal mesangial matrix in rats with diabetic nephropathy by inhibiting insulin-like growth factor-1.
    Ren W; Zhao C; Wang Y; Fang Y; Huang Z; Chen W; Wang L; Hu W; Wang K; Ni L
    Acta Cir Bras; 2019 Feb; 34(1):e20190010000007. PubMed ID: 30785508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are the Therapeutic Effects of Huangqi (
    Liao H; Hu L; Cheng X; Wang X; Li J; Banbury L; Li R
    J Immunol Res; 2017; 2017():3780572. PubMed ID: 29250558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
    Heidari Z; Gharebaghi A
    J Clin Diagn Res; 2017 May; 11(5):OC04-OC07. PubMed ID: 28658824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.